Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Surgical Oncology"
DOI: 10.1002/jso.26168
Abstract: To identify the optimal range and the minimum number of lymph nodes (LNs) to be examined to maximize survival time of patients with curatively resected gallbladder adenocarcinoma (GBAC).
read more here.
Keywords:
lymph nodes;
gallbladder adenocarcinoma;
number;
curatively resected ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of Gastrointestinal Surgery"
DOI: 10.1007/s11605-021-04942-1
Abstract: Gallbladder adenocarcinoma has a poor prognosis as it is often diagnosed incidentally, and patients have a high risk for residual and occult metastatic disease. Expert guidelines recommend definitive surgery for ≥T1b tumors; however, surgical management…
read more here.
Keywords:
gallbladder adenocarcinoma;
definitive resection;
decision making;
clinical decision ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "BMC Surgery"
DOI: 10.1186/s12893-020-00905-6
Abstract: Background Double primary cancers have a low incidence rate, and synchronous hepatocellular carcinoma and gallbladder adenocarcinoma are rarely reported. Here, we report such a case— the 12th case of synchronous double primary cancers featuring HCC…
read more here.
Keywords:
hepatocellular carcinoma;
synchronous hepatocellular;
carcinoma gallbladder;
gallbladder ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Histology and histopathology"
DOI: 10.14670/hh-11-824
Abstract: Mucins play pivotal roles in influencing cancer biology, for example affecting carcinoma invasion, aggressiveness and/or metastatic potential. Our aim is to investigate the significance of expression profiles of two mucins in particular, MUC1 and MUC2,…
read more here.
Keywords:
vessel invasion;
invasion;
muc1;
gallbladder adenocarcinoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Acta medica Iranica"
DOI: 10.18502/acta.v58i5.3957
Abstract: Her-2 (ErbB-2) is an oncogene frequently overexpressed in breast and gastric adenocarcinomas, and anti-Her-2 targeted therapy can be given to such patients. Her-2 overexpression and role of anti-Her-2 targeted therapy in cases of gallbladder adenocarcinomas…
read more here.
Keywords:
therapy;
potential target;
adenocarcinoma potential;
gallbladder ... See more keywords